The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy

The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy

Abstract Background Predicting the efficacy of immune-based therapy in patients with unresectable hepatocellular carcinoma (HCC) remains a clinical challenge. This study aims to evaluate the prognostic value of the systemic immune-inflammation index (SII) in forecasting treatment response and surviv...

Full description

Saved in:
Bibliographic Details
Main Authors: Tian He, Bin Xu, Lu-Na Wang, Zi-Yi Wang, Huan-Chen Shi, Cheng-Jie Zhong, Xiao-Dong Zhu, Ying-Hao Shen, Jian Zhou, Jia Fan, Hui-Chuan Sun, Bo Hu, Cheng Huang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Biomarker Research
Subjects:
Hepatocellular carcinoma
Immune-based therapy
Atezolizumab-bevacizumab
Systemic immune-inflammation index (SII)
Prognosis
Online Access:https://doi.org/10.1186/s40364-024-00722-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40364-024-00722-6

Similar Items